187 related articles for article (PubMed ID: 8420442)
1. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
Keilani T; Schlueter WA; Levin ML; Batlle DC
Ann Intern Med; 1993 Feb; 118(4):246-54. PubMed ID: 8420442
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
Schlueter W; Keilani T; Batlle DC
Am J Cardiol; 1993 Dec; 72(20):37H-44H. PubMed ID: 8285181
[TBL] [Abstract][Full Text] [Related]
3. Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia.
Wong H; Chahal N; Manlhiot C; Niedra E; McCrindle BW
JAMA Pediatr; 2013 Aug; 167(8):708-13. PubMed ID: 23733031
[TBL] [Abstract][Full Text] [Related]
4. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
[TBL] [Abstract][Full Text] [Related]
5. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
6. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
7. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
Marin R; Ruilope LM; Aljama P; Aranda P; Segura J; Diez J;
J Hypertens; 2001 Oct; 19(10):1871-6. PubMed ID: 11593109
[TBL] [Abstract][Full Text] [Related]
8. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A;
Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192
[TBL] [Abstract][Full Text] [Related]
9. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial.
Berthold HK; Sudhop T; von Bergmann K
JAMA; 1998 Jun; 279(23):1900-2. PubMed ID: 9634262
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
de Zeeuw D; Gansevoort RT; Dullaart RP; de Jong PE
J Hypertens Suppl; 1995 Jul; 13(1):S53-8. PubMed ID: 18800457
[TBL] [Abstract][Full Text] [Related]
11. Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.
Ruggenenti P; Mise N; Pisoni R; Arnoldi F; Pezzotta A; Perna A; Cattaneo D; Remuzzi G
Circulation; 2003 Feb; 107(4):586-92. PubMed ID: 12566371
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of fosinopril and herbal drug Dioscorea bulbifera in patients of diabetic nephropathy.
Singh RG; Rajak M; Ghosh B; ; Agrawal A; Dubey GP
Saudi J Kidney Dis Transpl; 2013 Jul; 24(4):737-42. PubMed ID: 23816723
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria.
Kincaid-Smith P; Fairley K; Packham D
Nephrol Dial Transplant; 2002 Apr; 17(4):597-601. PubMed ID: 11917051
[TBL] [Abstract][Full Text] [Related]
14. Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
Garg A; Grundy SM
Ann Intern Med; 1994 Sep; 121(6):416-22. PubMed ID: 8053615
[TBL] [Abstract][Full Text] [Related]
15. Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).
Diercks GF; Janssen WM; van Boven AJ; Bak AA; de Jong PE; Crijns HJ; van Gilst WH
Am J Cardiol; 2000 Sep; 86(6):635-8. PubMed ID: 10980214
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.
Maschio G; Cagnoli L; Claroni F; Fusaroli M; Rugiu C; Sanna G; Sasdelli M; Zuccalà A; Zucchelli P
Nephrol Dial Transplant; 1994; 9(3):265-9. PubMed ID: 8052432
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
Hayek T; Attias J; Coleman R; Brodsky S; Smith J; Breslow JL; Keidar S
Cardiovasc Res; 1999 Dec; 44(3):579-87. PubMed ID: 10690290
[TBL] [Abstract][Full Text] [Related]
19. Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia.
Maciejko JJ; Brazg R; Shah A; Patil S; Rubenfire M
Arch Fam Med; 1994 Nov; 3(11):955-60. PubMed ID: 7804477
[TBL] [Abstract][Full Text] [Related]
20. Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril.
Kowala MC; Recce R; Beyer S; Aberg G
J Cardiovasc Pharmacol; 1995 Feb; 25(2):179-86. PubMed ID: 7752642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
